FFM
CBPO

Fullerton Fund Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Fullerton Fund Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,100
Closed -$278K – 18
2015
Q3 		$278K Buy
+3,100
New +$327K 0.17% 12

Other funds holding CBPO

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fullerton Fund Management's CBPO Position: Q4 2015 in Review

Fullerton Fund Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2015, closing a stake of 3,100 shares — an estimated $278K sold.

Fullerton Fund Management first reported a position in CBPO in Q3 2015 and held it in 1 quarter. The position peaked at $278K in Q3 2015. 114 funds tracked by Wall St. Rank hold CBPO as of Q4 2015.

  • Fullerton Fund Management reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2015 after selling out during the quarter.
  • Fullerton Fund Management sold 3,100 China Biologic Products Holdings, Inc. shares in Q4 2015, an estimated $278K.
  • Fullerton Fund Management first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 1 quarter.
  • Fullerton Fund Management's China Biologic Products Holdings, Inc. position peaked at $278K in Q3 2015.
  • 114 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2015.

Based on Fullerton Fund Management's 13F filing for Q4 2015, filed 14 Feb 2017.